TrialMovement disorders : official journal of the Movement Disorder Society2025

Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial.

Mya C Schiess et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.